The present invention relates to heterocyclic-imidazole derivatives, a preparation method therefor and a medical use thereof, and particularly to new heterocyclic-imidazole derivatives as represented by general formula (I), a preparation method therefor, pharmaceutical compositions comprising same, and a use thereof as a therapeutic agent, particularly as a poly (ADP-ribose) polymerase (PARP) inhibitor.